Immunization with different viral antigens alters the pattern of T cell exhaustion and latency in herpes simplex virus type 1-infected mice

Journal of Virology

Volumn 84, Issue 23, 2010, Pages 12315-12324

  Allen, Sariah J ^a   Mott, Kevin R ^a   Zandian, Mandana ^a   Ghiasi, Homayon ^a  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN B; GLYCOPROTEIN D VACCINE; GLYCOPROTEIN K VACCINE; HERPES SIMPLEX VACCINE; IMMUNOGLOBULIN; KIDNEY INJURY MOLECULE 1; PROGRAMMED DEATH 1 LIGAND 1; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; CORNEA DISEASE; CORNEA SCARRING; DISEASE SEVERITY; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TRIGEMINUS GANGLION; VIRUS LATENCY; VIRUS LOAD; VIRUS REPLICATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION; ANTIGENS, VIRAL; CICATRIX; CORNEA; DNA PRIMERS; DNA, COMPLEMENTARY; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; POLYMERASE CHAIN REACTION; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIGEMINAL GANGLION; VIRAL PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

HUMAN HERPESVIRUS 1; MUS;

EID: 78049511214     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01600-10     Document Type: Article

References (57)

1. + T cells to immune senescence. J. Immunol. 183:4103-4108.
2. + T cells in corneas of ocularly infected mice. Virology 399: 11-22.
3. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439:682-687.
4. Bond, V. C., and S. Person. 1984. Fine structure physical map locations of alterations that affect cell fusion in herpes simplex virus type 1. Virology 132:368-376.
5. Reference deleted.
6. Chen, L., V. Pai, R. Levinson, A. H. Sharpe, G. J. Freeman, J. Braun, and L. K. Gordon. 2009. Constitutive neuronal expression of the immune regulator, programmed death 1 (PD-1), identified during experimental autoimmune uveitis. Ocul. Immunol. Inflamm. 17:47-55.
7. Chen, L., C. W. Sham, A. M. Chan, L. M. Francisco, Y. Wu, S. Mareninov, A. H. Sharpe, G. J. Freeman, X. J. Yang, J. Braun, and L. K. Gordon. 2009. Role of the immune modulator programmed cell death-1 during development and apoptosis of mouse retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 50:4941-4948.
8. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, Z. Mncube, J. Duraiswamy, B. Zhu, Q. Eichbaum, M. Altfeld, E. J. Wherry, H. M. Coovadia, P. J. Goulder, P. Klenerman, R. Ahmed, G. J. Freeman, and B. D. Walker. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443:350-354.
9. Debroy, C., N. Pederson, and S. Person. 1985. Nucleotide sequence of a herpes simplex virus type 1 gene that causes cell fusion. Virology 145:36-48. (Pubitemid 15234406)
10. + T cells is driven by viral replication and associated with T cell dysfunction. J. Immunol. 179:1979-1987.
11. Feldman, L. T., A. R. Ellison, C. C. Voytek, L. Yang, P. Krause, and T. P. Margolis. 2002. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc. Natl. Acad. Sci. U. S. A. 99:978-983.
12. + T cells in healthy carriers are continuously driven to replicative exhaustion. J. Immunol. 175:8218-8225.
13. Folkl, A., X. Wen, E. Kuczynski, M. E. Clark, and D. Bienzle. 2010. Feline programmed death and its ligand: characterization and changes with feline immunodeficiency virus infection. Vet. Immunol. Immunopathol. 134:107-114.
14. + Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J. Clin. Invest. 119:551-564. doi:10.1172/JCI36604.
15. Frank, G. M., A. J. Lepisto, M. L. Freeman, B. S. Sheridan, T. L. Cherpes, and R. L. Hendricks. 2010. Early CD4(+) T cell help prevents partial CD8(+) T cell exhaustion and promotes maintenance of herpes simplex virus 1 latency. J. Immunol. 184:277-286.
16. Fuller, M. J., and A. J. Zajac. 2003. Ablation of CD8 and CD4 T cell responses by high viral loads. J. Immunol. 170:477-486.
17. Ghiasi, H., S. Bahri, A. B. Nesburn, and S. L. Wechsler. 1995. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins. Invest. Ophthalmol. Vis. Sci. 36:1352-1360.
18. Ghiasi, H., S. Cai, S. Slanina, A. B. Nesburn, and S. L. Wechsler. 1997. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations. Invest. Ophthalmol. Vis. Sci. 38: 1213-1221.
19. Ghiasi, H., R. Kaiwar, A. B. Nesburn, S. Slanina, and S. L. Wechsler. 1994. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J. Virol. 68:2118-2126.
20. Ghiasi, H., S. Slanina, A. B. Nesburn, and S. L. Wechsler. 1994. Characterization of baculovirus-expressed herpes simplex virus type 1 glycoprotein K. J. Virol. 68:2347-2354.
21. Ghiasi, H., S. L. Wechsler, S. Cai, A. B. Nesburn, and F. M. Hofman. 1998. The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge. Immunology 95:352-359.
22. + T cells. J. Virol. 83:9122-9130.
23. Reference deleted.
24. Ha, S. J., S. N. Mueller, E. J. Wherry, D. L. Barber, R. D. Aubert, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2008. Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. J. Exp. Med. 205:543-555.
25. Hutchinson, L., K. Goldsmith, D. Snoddy, H. Ghosh, F. L. Graham, and D. C. Johnson. 1992. Identification and characterization of a novel herpes simplex virus glycoprotein, gK, involved in cell fusion. J. Virol. 66:5603-5609.
26. Jones, R. B., L. C. Ndhlovu, J. D. Barbour, P. M. Sheth, A. R. Jha, B. R. Long, J. C. Wong, M. Satkunarajah, M. Schweneker, J. M. Chapman, G. Gyenes, B. Vali, M. D. Hyrcza, F. Y. Yue, C. Kovacs, A. Sassi, M. Loutfy, R. Halpenny, D. Persad, G. Spotts, F. M. Hecht, T. W. Chun, J. M. McCune, R. Kaul, J. M. Rini, D. F. Nixon, and M. A. Ostrowski. 2008. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205:2763-2779.
27. Jurado, J. O., I. B. Alvarez, V. Pasquinelli, G. J. Martinez, M. F. Quiroga, E. Abbate, R. M. Musella, H. E. Chuluyan, and V. E. Garcia. 2008. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J. Immunol. 181:116-125.
28. + T cells during acute HCV infection, irrespective of clinical outcome. J. Virol. 82:3154-3160.
29. Kaufmann, D. E., and B. D. Walker. 2009. PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. J. Immunol. 182:5891-5897.
30. Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26:677-704.
31. Kramer, M. F., and D. M. Coen. 1995. Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 69:1389-1399.
32. Little, S. P., and P. A. Schaffer. 1981. Expression of the syncytial (syn) phenotype in HSV-1, strain KOS: genetic and phenotypic studies of mutants in two syn loci. Virology 112:686-702.
33. + T lymphocytes in the liver. J. Immunol. 178:2714-2720.
34. Margolis, T. P., F. L. Elfman, D. Leib, N. Pakpour, K. Apakupakul, Y. Imai, and C. Voytek. 2007. Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia. J. Virol. 81:11069-11074.
35. McGeoch, D. J., M. A. Dalrymple, A. J. Davison, A. Dolan, M. C. Frame, D. McNab, L. J. Perry, J. E. Scott, and P. Taylor. 1988. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69:1531-1574.
36. Monney, L., C. A. Sabatos, J. L. Gaglia, A. Ryu, H. Waldner, T. Chernova, S. Manning, E. A. Greenfield, A. J. Coyle, R. A. Sobel, G. J. Freeman, and V. K. Kuchroo. 2002. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415:536-541.
37. Moskophidis, D., F. Lechner, H. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758-761. (Erratum, 364:262.)
38. + T cells in trigeminal ganglia of latently infected mice. J. Virol. 83:2246-2254.
39. + T-cell epitope of herpes simplex virus on virus replication and pathogenicity. Invest. Ophthalmol. Vis. Sci. 50:2903-2912.
40. + T cells. Mol. Vis. 13:1802-1812.
41. Mott, K. R., G. C. Perng, Y. Osorio, K. G. Kousoulas, and H. Ghiasi. 2007. A recombinant herpes simplex virus type 1 expressing two additional copies of gK is more pathogenic than wild-type virus in two different strains of mice. J. Virol. 81:12962-12972.
42. Mueller, S. N., and R. Ahmed. 2009. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. U. S. A. 106:8623-8628.
43. Nakagawa, H., Y. Uchida, E. Takamura, Y. Nakagawa, H. Araki, and M. Watanabe. 1993. Diagnostic impression cytology for herpes simplex keratitis. Jpn. J. Ophthalmol. 37:505-513.
44. Nakamoto, N., H. Cho, A. Shaked, K. Olthoff, M. E. Valiga, M. Kaminski, E. Gostick, D. A. Price, G. J. Freeman, E. J. Wherry, and K. M. Chang. 2009. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog. 5:e1000313.
45. + T cells in patients with chronic hepatitis B virus infection. Viral Immunol. 23:63-70.
46. + T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood 110:928-936.
47. Pogue-Geile, K. L., and P. G. Spear. 1987. The single base pair substitution responsible for the Syn phenotype of herpes simplex virus type 1, strain MP. Virology 157:67-74.
48. Rodriguez-Manzanet, R., R. DeKruyff, V. K. Kuchroo, and D. T. Umetsu. 2009. The costimulatory role of TIM molecules. Immunol. Rev. 229:259-270.
49. Sabatos, C. A., S. Chakravarti, E. Cha, A. Schubart, A. Sanchez-Fueyo, X. X. Zheng, A. J. Coyle, T. B. Strom, G. J. Freeman, and V. K. Kuchroo. 2003. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat. Immunol. 4:1102-1110.
50. Sanchez-Fueyo, A., J. Tian, D. Picarella, C. Domenig, X. X. Zheng, C. A. Sabatos, N. Manlongat, O. Bender, T. Kamradt, V. K. Kuchroo, J. C. Gutierrez- Ramos, A. J. Coyle, and T. B. Strom. 2003. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat. Immunol. 4:1093-1101.
51. Sehrawat, S., P. B. Reddy, N. Rajasagi, A. Suryawanshi, M. Hirashima, and B. T. Rouse. 2010. Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. PLoS Pathog. 6:e1000882.
52. Sehrawat, S., A. Suryawanshi, M. Hirashima, and B. T. Rouse. 2009. Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J. Immunol. 182:3191-3201.
53. + T cells by rapid induction of multiple inhibitory receptors. J. Immunol. 184:4696-4707.
54. Velu, V., S. Kannanganat, C. Ibegbu, L. Chennareddi, F. Villinger, G. J. Freeman, R. Ahmed, and R. R. Amara. 2007. Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virusspecific CD8 T cells during chronic infection but not after vaccination. J. Virol. 81:5819-5828.
55. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77:4911-4927.
56. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. Sourdive, M. Suresh, J. D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-2213.
57. + Treg cells are associated with immunological remission of lupus. J. Immunol. 183:6346-6358.